Chronic But Not Acute Oral L-Arginine Supplementation Delays the Ventilatory Threshold During Exercise in Heart Failure Patients
Authors:
- Bertrand MettauerBMBertrand Mettauer
- François PiquardFPFrançois Piquard
- Adrien SchaeferASAdrien Schaefer
- Evelyne LonsdorferELEvelyne Lonsdorfer
- Ruddy RichardRRRuddy Richard
- Bernard GenyBGBernard Geny
- Roksana B. ZakRZRoksana B. Zak
- Clayton L. CamicCCClayton L. Camic
- Ethan C. HillEHEthan C. Hill
- Molly M. MonaghanMMMolly M. Monaghan
- Attila J. KovacsAKAttila J. Kovacs
- 1 August 2005
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Applied Physiology
- Vol. 30 (4) , 419-432
Abstract
The purpose of this study was to determine, in heart failure patients (HF), whether acute or chronic L-arginine supplementation (LAS) might delay the ventilatory threshold (VT) and whether chronic LAS might reduce exercise-induced plasma lactate increase. HF patients undertook 4 cardiopulmonary bicycle exercises tests. The first 3 were maximal without (EX1), after acute (EX2), or chronic (EX3) oral LAS (6 gm twice a day for 6 weeks). The 4th test (EX4), performed after chronic LAS, was similar to the first in order to investigate the effect of chronic LAS on circulating lactate levels. Results showed that acute LAS failed to improve both submaximal and maximal exercise capacities. Similarly, maximal exercise capacity remained unmodified after chronic LAS. Nevertheless, chronic LAS delayed significantly the patients' ventilatory threshold. Thus exercise duration prior to VT increased (mean ± SEM) from 6.04 ± 0.9 to 7.7 ± 1.03 min (p = 0.04), resulting in a significant increase in oxygen uptake (1.05 ± 0.08 to 1.24 ± 0.12 L•min−1; p = 0.03), CO2 release (0.94 ± 0.10 to 1.2 ± 0.12 L•min−1; p = 0.018), minute ventilation (29.31 ± 2.8 to 34.5 ± 2.7 L; p = 0.009), and workload (60.7 ± 9.8 to 78.5 ± 10.2 watts; p = 0.034). Furthermore, chronic LAS significantly reduced the exercise-induced increase in postexercise plasma lactate concentration (−21 ± 7%). In conclusion, unlike acute supplementation, chronic LAS significantly delays the ventilatory threshold, and chronic LAS reduces circulating plasma lactate in HF patients. These data suggest that chronic LAS might improve the ability of HF patients to perform their daily-life activities. Key words: maximal exercise, heart device, vasodilatorKeywords
This publication has 15 references indexed in Scilit:
- Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fasligand system in patients with chronic heart failureJACC, 2002
- L‐Arginine reduces heart rate and improves hemodynamics in severe congestive heart failureClinical Cardiology, 2000
- Nitric Oxide Biomarkers Increase During Exercise-Induced Vasodilation in the ForearmInternational Journal of Sports Medicine, 2000
- Intravenous l -arginine Reduces VE/VCO2 Slope Acutely in Patients with Severe Chronic Heart FailureEuropean Journal of Heart Failure, 1999
- L‐arginine‐induced vasodilation in healthy humans:pharmacokinetic–pharmacodynamic relationshipBritish Journal of Clinical Pharmacology, 1998
- Exercise capacity in heart transplant recipients: Relation to impaired endothelium-dependent vasodilation of the peripheral microcirculationAmerican Heart Journal, 1998
- Nitric Oxide-dependent Parasympathetic Signaling Is Due to Activation of Constitutive Endothelial (Type III) Nitric Oxide Synthase in Cardiac MyocytesJournal of Biological Chemistry, 1995
- Effects of motivation of the patient on indices of exercise capacity in chronic heart failure.Heart, 1994
- Dynamic knee extension as model for study of isolated exercising muscle in humansJournal of Applied Physiology, 1985
- Maximal perfusion of skeletal muscle in man.The Journal of Physiology, 1985